Editorial Team Key Takeaways
- The Supreme Court’s refusal to hear Hardeman v. Monsanto Co. on June 27, 2022, was a major win for plaintiffs. It means federal Roundup lawsuits based on a failure-to-warn theory can move forward because lower court rulings were left in place.
- Plaintiffs with Roundup cancer cases will keep pushing state-law tort claims that focus on bad labeling, since Monsanto’s federal preemption defense has mostly been shot down.
- If you have a non-Hodgkin lymphoma diagnosis and a history of heavy exposure to glyphosate herbicides, you need to talk to a lawyer to see if you have a case for compensation.
- The core of this litigation is that Roundup has a design defect and that Monsanto didn’t properly warn people about the cancer risks from glyphosate.
- Future cases will turn on proving a direct causal link between your Roundup exposure and your diagnosis, which almost always comes down to hiring the right scientific experts.
Recent court rulings have completely changed the game for anyone filing a Roundup lawsuit, especially when it comes to cancer warnings and product liability. The big one was on June 27, 2022, when the U.S. Supreme Court refused to hear an appeal in Hardeman v. Monsanto Co. That decision let a huge verdict against Monsanto stand and kept the Ninth Circuit’s reasoning intact. This denial directly affects the thousands of pending cases from people who say Roundup causes non-Hodgkin lymphoma and that the company hid the risks.
The Supreme Court’s Denial of Certiorari in Hardeman v. Monsanto Co.
When the Supreme Court refused to hear the appeal in Hardeman v. Monsanto Co., it slammed the door on a major legal strategy for Monsanto (now owned by Bayer AG). Edwin Hardeman’s case started it all. He got non-Hodgkin lymphoma after using Roundup on his property for decades. A federal jury in California gave him over $80 million, though a judge later cut it to $25 million. Monsanto’s main argument on appeal was that federal law preempted state-law claims about failure to warn. They said that because the EPA approved Roundup’s label under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), states couldn’t force them to add extra warnings. The Ninth Circuit Court of Appeals didn’t buy it and upheld the verdict. They found FIFRA didn’t give Monsanto a free pass from liability for failing to warn about dangers the EPA hadn’t specifically addressed. The Supreme Court’s refusal to even look at the case cemented this precedent. This is huge for plaintiffs. It means their cases can move forward, and the main fight will be about whether Monsanto told users what it should have about the potential dangers.
Impact on Existing and Future Roundup Claims
The Supreme Court’s move gives plaintiffs a much more predictable path forward in Roundup litigation. Before this, nobody was really sure if these state-law failure-to-warn claims would even survive. Now, with the preemption defense badly damaged (though Monsanto does keep trying to use it), plaintiffs can confidently file claims saying Monsanto knew or should have known glyphosate was carcinogenic but didn’t warn anyone. These lawsuits are still all about the alleged link between exposure to glyphosate, Roundup’s active ingredient, and getting non-Hodgkin lymphoma. The International Agency for Research on Cancer (IARC), which is part of the World Health Organization, called glyphosate “probably carcinogenic to humans” back in 2015. That IARC classification is the scientific backbone for plaintiffs’ arguments. The EPA has taken the opposite stance, saying glyphosate is “not likely to be carcinogenic to humans” when used correctly, but courts have consistently let juries hear both sides and decide for themselves. For people in Georgia thinking about a lawsuit, the legal framework is much more favorable now than a few years ago. We’ve seen federal courts, including our own Eleventh Circuit, consistently uphold a person’s right to sue for compensation if they can connect their non-Hodgkin lymphoma to Roundup exposure and prove Monsanto’s warnings were inadequate.
Understanding the “Design Defect” Argument in Roundup Litigation
Failure-to-warn is the main event in most Roundup cases, but a design defect argument is another powerful tool. A product has a design defect if it’s just plain dangerous by its nature, even if you use it exactly as the instructions say. For Roundup, the argument is that the formula itself is broken because it has glyphosate, an alleged carcinogen. Plaintiffs argue there were safer chemicals Monsanto could have used, or that the product could have been designed differently to reduce the risk. In Georgia, O.C.G.A. Section 51-1-11 is the legal foundation for product liability claims like this. The law says a manufacturer is liable if their product wasn’t fit for its intended use and its condition caused an injury. Proving a design defect is tough. You need an expert to get on the stand and show that the product’s design was unreasonably risky and that a safer, practical alternative was available back when it was made. The challenge in Roundup cases is proving an alternative would have been just as effective and affordable without killing the product’s usefulness. It’s a higher hurdle than a warning claim, but winning a design defect argument really strengthens a plaintiff’s overall case because it points to a problem with the product itself, not just the label. A warning label can only do so much. It can’t fix a product that’s inherently unsafe because of how it’s designed.
Who is Affected and What Steps Should They Take?
So who is this litigation for? It’s for people with heavy exposure to glyphosate-based herbicides who later got a non-Hodgkin lymphoma diagnosis. We’re talking about agricultural workers, landscapers, groundskeepers, and dedicated home gardeners who used Roundup for years. The time between exposure and diagnosis (the latency period) can be decades, so someone who used Roundup years ago might just be getting sick now. If you’ve been diagnosed with non-Hodgkin lymphoma after years of using Roundup, you need to act fast to protect your rights. 1. Consult with a Qualified Attorney: Get advice from a lawyer who does product liability and mass torts. They’ll look at your exposure history and medical diagnosis to see if you have a case. Lots of firms offer a free first meeting. Take it. It’s your chance to figure out your options without spending a dime.
2. Gather Documentation: Start collecting every medical record you can find about your non-Hodgkin lymphoma, biopsy results, pathology reports, doctor’s notes, treatment plans. You also need proof of Roundup use. This could be receipts, work records showing you sprayed it for a job, or even just your own detailed account of how and when you used it.
3. Understand Statutes of Limitations: This is a big one. In Georgia, you generally have two years to file a personal injury or product liability claim from the date you were diagnosed or reasonably should have known Roundup might have caused your illness. The law is O.C.G.A. Section 9-3-33. If you miss that deadline, your claim is likely gone for good.
4. Avoid Discussing Your Case Publicly: Don’t post about your health or your lawsuit on social media. Don’t talk about it with anyone but your lawyer. Anything you say can and will be twisted and used against you in court. These cases are complicated, you’re dealing with complex science and legal tactics. You need a lawyer who’s been there before. Going toe-to-toe with a huge company like Bayer means digging through mountains of documents in discovery, hiring the right expert witnesses, and knowing how to negotiate. That takes real experience in mass torts.
The Future of Roundup Litigation and Potential Settlements
Now that the Supreme Court has weighed in on Hardeman, the ground under Roundup plaintiffs is a lot more solid. Bayer is still fighting new lawsuits, but it has also been trying to settle them. Back in 2020, Bayer announced a huge settlement program to clear out a big chunk of the pending claims. That program didn’t cover everyone, though, and people are still filing new lawsuits today. From what we’re seeing, future settlements and jury verdicts are going to keep hammering on both failure-to-warn and, sometimes, design defect claims. The whole fight over whether glyphosate causes cancer will continue to be a battle of the experts, with both sides bringing in their own scientists to testify in courtrooms like Fulton County Superior Court. I’ve seen it time and again in these big product liability cases: defendants try to settle huge blocks of claims at once. It’s a way to control the financial bleeding and manage their public image. But that doesn’t mean your case is automatic. Every single claim has to be built from the ground up with solid evidence. How strong is your claim? It really comes down to the facts of your exposure, the specifics of your non-Hodgkin lymphoma, and whether you have good medical records to back it all up. A big settlement might set the general terms, but what you actually receive can be very different from someone else’s case. You have to understand that even with good court rulings on your side, nothing is guaranteed. Winning takes work. Look, the road ahead for anyone hurt by Roundup is long, but these recent court decisions have at least cleared a lot of the brush out of the way.
Why was the Supreme Court’s decision so important for Roundup lawsuits?
The Supreme Court’s refusal to hear the Hardeman v. Monsanto Co. appeal on June 27, 2022, was a big deal. It meant a lower court ruling stood which had rejected Monsanto’s argument that federal label approval protected them from lawsuits. Because of this, plaintiffs can keep suing under state law, arguing that Monsanto failed to warn them about the cancer risks.
What does “design defect” mean in a Roundup case?
A “design defect” claim argues that the problem isn’t the warning label, it’s the product itself. The lawsuit alleges that Roundup’s formula, with glyphosate as the active ingredient, is just unreasonably dangerous. The argument is that a safer, effective alternative could have and should have been used instead.
What cancer is linked to Roundup in these lawsuits?
Non-Hodgkin lymphoma is the main cancer at the center of the Roundup lawsuits. While some other related cancers might be involved in certain cases, non-Hodgkin lymphoma is what the vast majority of these claims are about.
Is it too late to file a Roundup lawsuit in Georgia?
Yes, there’s a deadline. In Georgia, the statute of limitations for product liability cases is typically two years from when you were diagnosed or when you reasonably should have known your illness was linked to Roundup. That’s under O.C.G.A. Section 9-3-33. You have to talk to an attorney right away to make sure you don’t miss that window.
What proof do I need for a Roundup cancer lawsuit?
Generally, you’ll need a few key things: medical records that officially diagnose you with non-Hodgkin lymphoma, proof that you were exposed to Roundup (like receipts or work records), and expert testimony from a doctor connecting your cancer to that exposure. A good lawyer will help you pull all this together.
